当前位置: X-MOL 学术ACS Nano › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction to Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth.
ACS Nano ( IF 15.8 ) Pub Date : 2020-01-13 , DOI: 10.1021/acsnano.0c00042
Jiayan Lang , Xiao Zhao , Xiuchao Wang , Ying Zhao , Yiye Li , Ruifang Zhao , Keman Cheng , Yao Li , Xuexiang Han , Xiaowei Zheng , Hao Qin , Marzieh Geranpayehvaghei , Jian Shi , Gregory J. Anderson , Jihui Hao , He Ren , Guangjun Nie

The authors regret that some incorrect images were inadvertently used when VEGF expression was shown in the TNP-DFO and TNP-DFO-YC1 groups of Figure 6E. This error occurred during the assembly of the figure. The correct images have now been incorporated. These corrections do not change the conclusions, the text of the article, or the figure legend. The authors apologize for any inconvenience caused to readers. This article has not yet been cited by other publications.

中文翻译:

铁螯合剂去铁胺和HIF1α抑制剂靶向共递送的校正会损害胰腺肿瘤的生长。

作者感到遗憾的是,当图6E的TNP-DFO和TNP-DFO-YC1组显示VEGF表达时,无意中使用了一些错误的图像。在组装图形期间发生此错误。现已包含正确的图像。这些更正不会更改结论,文章的文字或图例。对于给读者带来的任何不便,作者深表歉意。本文尚未被其他出版物引用。
更新日期:2020-01-13
down
wechat
bug